Loading…

Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases

Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2017-05, Vol.8, p.521
Main Authors: Fröhlich, Eleonore, Wahl, Richard
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3
cites cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3
container_end_page
container_issue
container_start_page 521
container_title Frontiers in immunology
container_volume 8
creator Fröhlich, Eleonore
Wahl, Richard
description Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.
doi_str_mv 10.3389/fimmu.2017.00521
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544</doaj_id><sourcerecordid>28536577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</originalsourceid><addsrcrecordid>eNpVkctKAzEUhoMoKtq9K5kXmJrrJONCKN5BEKQuJWSSkzYynchkKvbtTVsrmkUuJ_m_kHwInRE8ZkzVFz4sFssxxUSOMRaU7KFjUlW8ZJTy_T_zIzRK6R3nxmvGmDhER1QJVgkpj9HbdL7qY3DFZDnENbALw-qyeIktFNEXk24I5bA7khdNdAFSEbpiFzSdK26_ht6UPxXTFjchgUmQTtGBN22C0c94gl7vbqfXD-XT8_3j9eSptIKqoZTWY0KrhniXO0ENVtIDU04pU1viZdN44lxDDXhRG0ZIxWsqreQEew-WnaDHLddF864_-rAw_UpHE_SmEPuZNv0QbAvaZA62QirSeO4tKCBgMQAXrK4E55l1tWV9LJsFOAtdflv7D_p_pwtzPYufWvD82VJlAN4CbB9T6sH_ZgnWa3N6Y06vzemNuRw5_3vnb2DniX0DeSaYWw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><source>PubMed Central</source><creator>Fröhlich, Eleonore ; Wahl, Richard</creator><creatorcontrib>Fröhlich, Eleonore ; Wahl, Richard</creatorcontrib><description>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2017.00521</identifier><identifier>PMID: 28536577</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>autoimmune thyroiditis ; Graves’ orbitopathy ; Immunology ; thyroglobulin ; thyroid autoantibodies ; thyroid peroxidase ; thyroid-stimulating hormone receptor</subject><ispartof>Frontiers in immunology, 2017-05, Vol.8, p.521</ispartof><rights>Copyright © 2017 Fröhlich and Wahl. 2017 Fröhlich and Wahl</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</citedby><cites>FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422478/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422478/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28536577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fröhlich, Eleonore</creatorcontrib><creatorcontrib>Wahl, Richard</creatorcontrib><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</description><subject>autoimmune thyroiditis</subject><subject>Graves’ orbitopathy</subject><subject>Immunology</subject><subject>thyroglobulin</subject><subject>thyroid autoantibodies</subject><subject>thyroid peroxidase</subject><subject>thyroid-stimulating hormone receptor</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctKAzEUhoMoKtq9K5kXmJrrJONCKN5BEKQuJWSSkzYynchkKvbtTVsrmkUuJ_m_kHwInRE8ZkzVFz4sFssxxUSOMRaU7KFjUlW8ZJTy_T_zIzRK6R3nxmvGmDhER1QJVgkpj9HbdL7qY3DFZDnENbALw-qyeIktFNEXk24I5bA7khdNdAFSEbpiFzSdK26_ht6UPxXTFjchgUmQTtGBN22C0c94gl7vbqfXD-XT8_3j9eSptIKqoZTWY0KrhniXO0ENVtIDU04pU1viZdN44lxDDXhRG0ZIxWsqreQEew-WnaDHLddF864_-rAw_UpHE_SmEPuZNv0QbAvaZA62QirSeO4tKCBgMQAXrK4E55l1tWV9LJsFOAtdflv7D_p_pwtzPYufWvD82VJlAN4CbB9T6sH_ZgnWa3N6Y06vzemNuRw5_3vnb2DniX0DeSaYWw</recordid><startdate>20170509</startdate><enddate>20170509</enddate><creator>Fröhlich, Eleonore</creator><creator>Wahl, Richard</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170509</creationdate><title>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</title><author>Fröhlich, Eleonore ; Wahl, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>autoimmune thyroiditis</topic><topic>Graves’ orbitopathy</topic><topic>Immunology</topic><topic>thyroglobulin</topic><topic>thyroid autoantibodies</topic><topic>thyroid peroxidase</topic><topic>thyroid-stimulating hormone receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fröhlich, Eleonore</creatorcontrib><creatorcontrib>Wahl, Richard</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fröhlich, Eleonore</au><au>Wahl, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2017-05-09</date><risdate>2017</risdate><volume>8</volume><spage>521</spage><pages>521-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Autoimmune diseases have a high prevalence in the population, and autoimmune thyroid disease (AITD) is one of the most common representatives. Thyroid autoantibodies are not only frequently detected in patients with AITD but also in subjects without manifest thyroid dysfunction. The high prevalence raises questions regarding a potential role in extra-thyroidal diseases. This review summarizes the etiology and mechanism of AITD and addresses prevalence of antibodies against thyroid peroxidase, thyroid-stimulating hormone receptor (TSHR), and anti-thyroglobulin and their action outside the thyroid. The main issues limiting the reliability of the conclusions drawn here include problems with different specificities and sensitivities of the antibody detection assays employed, as well as potential confounding effects of altered thyroid hormone levels, and lack of prospective studies. In addition to the well-known effects of TSHR antibodies on fibroblasts in Graves' disease (GD), studies speculate on a role of anti-thyroid antibodies in cancer. All antibodies may have a tumor-promoting role in breast cancer carcinogenesis despite anti-thyroid peroxidase antibodies having a positive prognostic effect in patients with overt disease. Cross-reactivity with lactoperoxidase leading to induction of chronic inflammation might promote breast cancer, while anti-thyroid antibodies in manifest breast cancer might be an indication for a more active immune system. A better general health condition in older women with anti-thyroid peroxidase antibodies might support this hypothesis. The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28536577</pmid><doi>10.3389/fimmu.2017.00521</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2017-05, Vol.8, p.521
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_addb0c5781bf4fce8e1ec0ee45396544
source PubMed Central
subjects autoimmune thyroiditis
Graves’ orbitopathy
Immunology
thyroglobulin
thyroid autoantibodies
thyroid peroxidase
thyroid-stimulating hormone receptor
title Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A25%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20Autoimmunity:%20Role%20of%20Anti-thyroid%20Antibodies%20in%20Thyroid%20and%20Extra-Thyroidal%20Diseases&rft.jtitle=Frontiers%20in%20immunology&rft.au=Fr%C3%B6hlich,%20Eleonore&rft.date=2017-05-09&rft.volume=8&rft.spage=521&rft.pages=521-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2017.00521&rft_dat=%3Cpubmed_doaj_%3E28536577%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-7cf0126b1fd6b152a087fe38d88a9c1f7bbf1ddb2aef59a31164927c7410ffec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28536577&rfr_iscdi=true